BECTON, DICKINSON AND COMPANY Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
BECTON, DICKINSON AND COMPANY (BDX) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $287.00 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-05.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2014-05-05
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2014-03-31 was $287.00M, a 3.99% increase year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2013-12-31 was $271.00M, a 56.64% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2013-09-30 was $90.38M, a 68.74% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2013-06-30 was $301.55M, a 7.75% decline year-over-year.
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for fiscal 2013 was $1.29B, a 10.51% increase from fiscal 2012.
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for fiscal 2012 was $1.17B, a 7.95% decline from fiscal 2011.
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for fiscal 2011 was $1.27B, a 3.54% decline from fiscal 2010.
- BECTON, DICKINSON AND COMPANY net income (loss), including portion attributable to noncontrolling interest for fiscal 2010 was $1.32B, a 6.98% increase from fiscal 2009.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2014-03-31 | $287.00M 10-Q · filed 2014-05-05 | $558.00M 10-Q · filed 2014-05-05 | $648.38M derived: sum of 3 quarters · filed 2014-05-05 | $949.93M derived: sum of 4 quarters · filed 2014-05-05 | |||
| 2013-12-31 | $271.00M 10-Q · filed 2014-02-10 | $361.38M derived: sum of 2 quarters · filed 2014-02-10 | $662.93M derived: sum of 3 quarters · filed 2014-02-10 | $938.56M derived: sum of 4 quarters · filed 2014-02-10 | |||
| 2013-09-30 | $90.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $391.93M derived: sum of 2 quarters · filed 2013-11-27 | $667.56M derived: sum of 3 quarters · filed 2013-11-27 | $1.29B 10-K · filed 2013-11-27 | |||
| 2013-06-30 | $301.55M 10-Q · filed 2013-08-05 | $577.19M derived: sum of 2 quarters · filed 2013-08-05 | $1.20B 10-Q · filed 2013-08-05 | $1.49B derived: sum of 4 quarters · filed 2014-02-10 | |||
| 2013-03-31 | $276.00M 10-Q · filed 2014-05-05 | $901.00M 10-Q · filed 2014-05-05 | $901.07M 10-Q · filed 2013-05-09 | $1.19B derived: sum of 3 quarters · filed 2014-02-10 | $1.52B derived: sum of 4 quarters · filed 2014-02-10 | ||
| 2012-12-31 | $625.00M 10-Q · filed 2014-02-10 | $625.44M 10-Q · filed 2013-02-07 | $914.12M derived: sum of 2 quarters · filed 2014-02-10 | $1.24B derived: sum of 3 quarters · filed 2014-02-10 | $1.53B derived: sum of 4 quarters · filed 2014-02-10 | ||
| 2012-09-30 | $289.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $615.98M derived: sum of 2 quarters · filed 2013-11-27 | $907.01M derived: sum of 3 quarters · filed 2013-11-27 | $1.17B 10-K · filed 2013-11-27 | $1.17B 10-K · filed 2012-11-21 | ||
| 2012-06-30 | $326.87M 10-Q · filed 2013-08-05 | $617.90M derived: sum of 2 quarters · filed 2013-08-05 | $880.88M 10-Q · filed 2013-08-05 | $1.18B derived: sum of 4 quarters · filed 2013-11-27 | |||
| 2012-03-31 | $291.03M 10-Q · filed 2013-05-09 | $554.02M 10-Q · filed 2013-05-09 | $854.00M derived: sum of 3 quarters · filed 2013-11-27 | $1.20B derived: sum of 4 quarters · filed 2013-11-27 | |||
| 2011-12-31 | $262.99M 10-Q · filed 2013-02-07 | $562.97M derived: sum of 2 quarters · filed 2013-11-27 | $906.03M derived: sum of 3 quarters · filed 2013-11-27 | $1.22B derived: sum of 4 quarters · filed 2013-11-27 | |||
| 2011-09-30 | $299.99M derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $643.04M derived: sum of 2 quarters · filed 2013-11-27 | $955.06M derived: sum of 3 quarters · filed 2013-11-27 | $1.27B 10-K · filed 2013-11-27 | $1.27B 10-K · filed 2011-11-23 | ||
| 2011-06-30 | $343.06M 10-Q · filed 2012-08-06 | $655.08M derived: sum of 2 quarters · filed 2012-08-06 | $971.01M 10-Q · filed 2012-08-06 | $1.37B derived: sum of 4 quarters · filed 2012-11-21 | |||
| 2011-03-31 | $312.02M 10-Q · filed 2012-05-03 | $627.96M 10-Q · filed 2012-05-03 | $1.02B derived: sum of 3 quarters · filed 2012-11-21 | $1.33B derived: sum of 4 quarters · filed 2012-11-21 | |||
| 2010-12-31 | $315.94M 10-Q · filed 2012-02-07 | $712.63M derived: sum of 2 quarters · filed 2012-11-21 | $1.02B derived: sum of 3 quarters · filed 2012-11-21 | $1.32B derived: sum of 4 quarters · filed 2012-11-21 | |||
| 2010-09-30 | $396.69M derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-21 | $703.60M derived: sum of 2 quarters · filed 2012-11-21 | $1.00B derived: sum of 3 quarters · filed 2012-11-21 | $1.32B 10-K · filed 2012-11-21 | |||
| 2010-06-30 | $306.91M 10-Q · filed 2011-08-02 | $604.54M derived: sum of 2 quarters · filed 2011-08-02 | $920.91M 10-Q · filed 2011-08-02 | $1.24B derived: sum of 4 quarters · filed 2011-11-23 | |||
| 2010-03-31 | $297.63M 10-Q · filed 2011-05-04 | $614.01M 10-Q · filed 2011-05-04 | $931.23M derived: sum of 3 quarters · filed 2011-11-23 | $1.27B derived: sum of 4 quarters · filed 2011-11-23 | |||
| 2009-12-31 | $316.38M 10-Q · filed 2011-02-08 | $633.60M derived: sum of 2 quarters · filed 2011-11-23 | $974.62M derived: sum of 3 quarters · filed 2011-11-23 | ||||
| 2009-09-30 | $317.22M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-23 | $658.25M derived: sum of 2 quarters · filed 2011-11-23 | $1.23B 10-K · filed 2011-11-23 | ||||
| 2009-06-30 | $341.03M 10-Q · filed 2010-08-04 | $914.38M 10-Q · filed 2010-08-04 | |||||
| 2008-09-30 | $1.13B 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |